Re: Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer: M. L. Blute, Jr., T. J. Rushmer, F. Shi, B. J. Fuller, E. J. Abel, D. F. Jarrard and T. M. Downs J Urol 2015;194:1214-1219
- PMID: 26876585
- DOI: 10.1016/j.juro.2015.12.091
Re: Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer: M. L. Blute, Jr., T. J. Rushmer, F. Shi, B. J. Fuller, E. J. Abel, D. F. Jarrard and T. M. Downs J Urol 2015;194:1214-1219
Comment in
-
Reply by Authors.J Urol. 2016 May;195(5):1623-1624. doi: 10.1016/j.juro.2015.12.111. Epub 2016 Feb 12. J Urol. 2016. PMID: 26876587 No abstract available.
Comment on
-
Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.J Urol. 2015 Nov;194(5):1214-9. doi: 10.1016/j.juro.2015.05.104. Epub 2015 Jul 11. J Urol. 2015. PMID: 26173101 Free PMC article.
Similar articles
-
Re: Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer: M. L. Blute, Jr., T. J. Rushmer, F. Shi, B. J. Fuller, E. J. Abel, D. F. Jarrard and T. M. Downs J Urol 2015;194:1214-1219.J Urol. 2016 Sep;196(3):960-1. doi: 10.1016/j.juro.2016.03.184. Epub 2016 Jun 11. J Urol. 2016. PMID: 27294294 No abstract available.
-
Re: Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus: E. J. Abel, T. A. Masterson, J. A. Karam, V. A. Master, V. Margulis, R. Hutchinson, C. A. Lorentz, E. Bloom, T. M. Bauman, C. G. Wood and M. L. Blute, Jr. J Urol 2017;198:810-816.J Urol. 2018 Mar;199(3):853-854. doi: 10.1016/j.juro.2017.09.142. Epub 2017 Nov 24. J Urol. 2018. PMID: 29178998 No abstract available.
-
Commentary on "economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases." Lee CT, Barocas D, Globe DR, Oefelein MG, Colayco DC, Bruno A, O׳Day K, Bramley T, Department of Urology, University of Michigan, Ann Arbor, MI.: J Urol 2012;188(6):2114-9. [Epub 2012 Oct 18]. doi: 10.1016/j.juro.2012.08.005.Urol Oncol. 2014 Oct;32(7):1089. doi: 10.1016/j.urolonc.2014.03.001. Epub 2014 Oct 29. Urol Oncol. 2014. PMID: 25443143
-
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.J Urol. 2011 Dec;186(6):2158-67. doi: 10.1016/j.juro.2011.07.076. Epub 2011 Oct 19. J Urol. 2011. PMID: 22014799 Review.
-
Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?Curr Opin Urol. 2008 Sep;18(5):504-7. doi: 10.1097/MOU.0b013e32830b86a9. Curr Opin Urol. 2008. PMID: 18670275 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical